Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein

a technology of amyloid beta plaque and tau protein, applied in the field of phytic acid and phytate for the treatment of alzheimer's disease, can solve problems such as burdensome doses, and achieve the effect of preventing the occurrence of potential side effects, treating and preventing the aggregation of beta amyloid proteins

Inactive Publication Date: 2020-03-12
SABIN ROBERT
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes the use of low doses of phytic acid, phytate salt, or a mixture of these substances to treat and prevent the buildup of beta amyloid proteins in the brains of Alzheimer's patients. These low doses have fewer side effects and are easier to administer to patients who may have difficulty taking high doses. The text also notes that phytic acid and its compounds are more effective than other alternatives such as scyllo inositol and myo inositol.

Problems solved by technology

This dose is burdensome.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein
  • Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein
  • Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein

Examples

Experimental program
Comparison scheme
Effect test

examples

[0039]The Applicant tested compounds disclosed in the above referenced patents of Sabin using well established standard routine testing, as known in the art, at Oregon Science and Health University in an in-vitro challenge test.

[0040]The Applicant submits two pages of the data of these in vitro tests. In the first test, phytic acid attenuates APP CTF-induced neurotoxicity. APP is a precursor / source to beta amyloid plaque and is considered by many to be a “bad actor”, “cause”, of Alzheimer's Disease. See DDN BENCH PRESS. Neither scyllo inositol nor myo inositol previously used by Barak et al, “inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial”, Prog. Neuro-Psychopharmacol. & Biol. Psychiatry., 20(4): 729-735, 1996 attenuated APP CTF-induced neurotoxicity. Phytic acid is shown to be active, while scyllo inositol and myo inositol are shown to be inactive. These surprising and unexpected results with phytic acid attenuating APP CTF-induced ne...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
body weightaaaaaaaaaa
body weightaaaaaaaaaa
weightaaaaaaaaaa
Login to View More

Abstract

A composition and method for the treatment of Alzheimer's disease and related amyloid plaque development and reduction of amyloid plaque, amyloidosis and amyotrophic lateral sclerosis, includes an effective amount of a compound selected from the group consisting of phytic acid, a phytate salt, an isomer or hydrolysate of phytic acid or a phytate salt, or a mixture of any combination thereof, being administered to a person in an amount from about 0.5 grams to about 18.75 grams per day.

Description

RELATED APPLICATIONS[0001]This application is a continuation of application Ser. No. 12 / 661,964, filed Mar. 26, 2010, which '964 application is incorporated by reference herein and claims benefit therefrom under 35 USC section 120. This application and the aforementioned '964 application are based upon, and claim priority under 35 USC 119 (e), from provisional application No. 61 / 211,230 filed Mar. 27, 2009 and provisional application No. 61 / 273,126, filed Jul. 29, 2009. The '230 and the '126 provisional applications are incorporated by reference herein.[0002]All Patents, Scientific Articles, and other Documents mentioned herein are incorporated by reference as if reproduced in full below.FIELD OF THE INVENTION[0003]This invention relates to the prophylactic and therapeutic treatment of Alzheimer's Disease, herein-below identified as “AD”.BACKGROUND OF THE INVENTION[0004]Phytic acid, generally accepted as having the structure myo-inositol-hexakis (dihydrogen phosphate), is a major co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/66A61K9/19A61K9/00A61K9/20
CPCA61K9/19A61K9/0014A61K9/0021A61K9/2004A61K9/0095A61K31/66A61P25/00A61P25/28A61K31/6615
Inventor SABIN, ROBERT
Owner SABIN ROBERT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com